NO942899D0 - - Google Patents

Info

Publication number
NO942899D0
NO942899D0 NO942899A NO942899A NO942899D0 NO 942899 D0 NO942899 D0 NO 942899D0 NO 942899 A NO942899 A NO 942899A NO 942899 A NO942899 A NO 942899A NO 942899 D0 NO942899 D0 NO 942899D0
Authority
NO
Norway
Prior art keywords
stabilization
radiopharmaceutical
relates
present
components
Prior art date
Application number
NO942899A
Other languages
English (en)
Other versions
NO942899L (no
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of NO942899L publication Critical patent/NO942899L/no
Publication of NO942899D0 publication Critical patent/NO942899D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO942899A 1992-02-14 1994-08-04 Stabiliserte, radiofarmasöytiske sett NO942899L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,644 US5300280A (en) 1992-02-14 1992-02-14 Stabilized radiopharmaceutical kits
PCT/US1993/001196 WO1993015765A1 (en) 1992-02-14 1993-02-09 Stabilized radiopharmaceutical kits

Publications (2)

Publication Number Publication Date
NO942899L NO942899L (no) 1994-08-04
NO942899D0 true NO942899D0 (no) 1994-08-04

Family

ID=25272404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942899A NO942899L (no) 1992-02-14 1994-08-04 Stabiliserte, radiofarmasöytiske sett

Country Status (15)

Country Link
US (2) US5300280A (no)
EP (2) EP1690552A3 (no)
JP (1) JPH07503960A (no)
AT (1) ATE378073T1 (no)
AU (1) AU3662493A (no)
BG (1) BG98971A (no)
CA (1) CA2129755C (no)
DE (1) DE69334183T2 (no)
FI (1) FI943724A (no)
HU (1) HUT74566A (no)
IL (1) IL104655A (no)
NO (1) NO942899L (no)
SK (1) SK96694A3 (no)
WO (1) WO1993015765A1 (no)
ZA (1) ZA93949B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
AU6493894A (en) * 1993-03-31 1994-10-24 Mallinckrodt Medical, Inc. Radiopharmaceutical formulations having non-stannous reductants
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
IT1289660B1 (it) * 1996-10-03 1998-10-16 Sorin Biomedica Diagnost Spa Procedimento per la riduzione di composti ossigenati del renio o del tecnezio
WO1998029139A1 (en) * 1996-12-25 1998-07-09 Gosudarstvenny Nauchny Tsentr Fiziko-Energetichesky Institut PREPARATION CONTAINING AN ORGANIC COMPOUND LABELLED WITH A β RADIONUCLIDE
NZ507949A (en) 1998-09-25 2002-03-01 Tokyo Gas Co Ltd C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
US6905668B1 (en) * 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
US6056941A (en) * 1999-07-28 2000-05-02 Bracco Research Usa Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
JP2008503493A (ja) * 2004-06-17 2008-02-07 アナザオヘルス コーポレーション 腫瘍を破壊するための安定化され凍結乾燥された放射性薬剤
US20070189965A1 (en) * 2004-06-17 2007-08-16 Kuperus John H Copper-complex isonitrile positron emission tomography (pet) imaging agent and method
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219270A (ja) * 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH064770B2 (ja) * 1984-07-31 1994-01-19 三菱電機株式会社 ジチオラト錯体−シクロデキストリン包接化合物の製造方法
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4714605A (en) * 1986-10-14 1987-12-22 E. R. Squibb & Sons, Inc. Technetium-99m labeled dioxime complexes
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5026913A (en) * 1989-12-12 1991-06-25 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol derivatives
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5112595A (en) * 1990-12-21 1992-05-12 Mallinckrodt Medical, Inc. 99MTC(III) myocardial imaging agents and method of use

Also Published As

Publication number Publication date
ZA93949B (en) 1993-12-07
IL104655A (en) 1998-06-15
AU3662493A (en) 1993-09-03
FI943724A0 (fi) 1994-08-12
EP1690552A3 (en) 2008-07-02
BG98971A (en) 1995-06-30
HU9402349D0 (en) 1994-10-28
WO1993015765A1 (en) 1993-08-19
EP0625054B1 (en) 2007-11-14
FI943724A (fi) 1994-08-12
EP0625054A4 (en) 1996-04-17
US6428768B1 (en) 2002-08-06
DE69334183T2 (de) 2008-11-06
NO942899L (no) 1994-08-04
CA2129755C (en) 2006-01-03
EP1690552A2 (en) 2006-08-16
CA2129755A1 (en) 1993-08-15
DE69334183D1 (de) 2007-12-27
IL104655A0 (en) 1993-06-10
JPH07503960A (ja) 1995-04-27
EP0625054A1 (en) 1994-11-23
HUT74566A (en) 1997-01-28
US5300280A (en) 1994-04-05
ATE378073T1 (de) 2007-11-15
SK96694A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
NO942899D0 (no)
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
AU2724492A (en) Antibodies in immunosuppression
CA2142861A1 (en) Novel Uses of IL-4 and/or IL-10, and Antibodies Against the Same
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
EP0599532A3 (en) One-component crosslinkable organosiloxane compositions.
BG101851A (en) Hepatitis vaccine
AU7528894A (en) Hydrazino-type n2s2 chelators
AU4257193A (en) Turbo compounder
AU1378395A (en) Metal chelators
EP0656030A4 (en) STABILIZING SYSTEM FOR THE COMPOSITIONS OF THIOL-ENES AND THIOL-NENES.
AU631681B2 (en) Radiolabeled anticoagulant peptides
MY114140A (en) Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy.
TW257750B (no)
EP0624621A3 (en) Glass reinforced PC / ABS mixture.
GR3015468T3 (en) Inclusion compounds of nimesulide with cyclodextrins.
AU3711597A (en) A novel galanin receptor
ZA945708B (en) Rye-flour
EP0632580A3 (de) Verstärkerausgangsstufe.
CA2171728A1 (en) Triaryl-ethylene derivatives for use in therapy
GR3007486T3 (no)
AU2859892A (en) Aminoalkyl-substituted 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
EP0658625A3 (fr) Protéine susceptible d'être biotinylée utilisable pour la détermination du stade de germination d'une semence.
FR2710017B1 (fr) Perfectionnements aux brouettes.
AU115632S (en) Door handle